UCLA research could lead to a simple saliva test capable of diagnosing — at an early stage — diabetes and cancer, and perhaps neurological disorders and autoimmune diseases.
The study, the most comprehensive analysis ever conducted of RNA molecules in human saliva, reveals that saliva contains many of the same disease-revealing molecules that are contained in blood. It was published online today by the peer-reviewed journal Clinical Chemistry and will be published in the journal’s January 2015 special print issue, “Molecular Diagnostics: A Revolution in Progress.”
“If we can define the boundaries of molecular targets in saliva, then we can ask what the constituents in saliva are that can mark someone who has pre-diabetes or the early stages of oral cancer or pancreatic cancer — and we can utilize this knowledge for personalized medicine,” said Dr. David Wong, a senior author of the research and UCLA’s Felix and Mildred Yip Endowed Professor in Dentistry.
Wong said the test also holds promise for diagnosing Type 2 diabetes, gastric cancer and other diseases. “If you don’t look in saliva, you may miss important indicators of disease,” Wong said. “There seems to be treasure in saliva, which will surprise people.”
RNA, widely known as a cellular messenger that makes proteins and carries out DNA’s instructions to other parts of the cell, is now understood to perform sophisticated chemical reactions and is believed to perform an extraordinary number of other functions, at least some of which are unknown.
Wong’s research over the past decade has focused on identifying biomarkers in saliva. His laboratory discovered that some of the same RNA that is inside human cells are also present in saliva and can be used to detect diseases — a surprising finding, he said, because enzymes in saliva can degrade RNA, making the mouth “a hostile environment.”
The new research is a collaboration with Xinshu (Grace) Xiao, the paper’s other senior author and a UCLA associate professor of integrative biology and physiology in the UCLA College. Using state-of-the-science genomics and bioinformatics, the researchers analyzed 165 million genetic sequences.
Among the many forms of RNA are some unusual ones that live in the mouth and in cells. For example, it wasn’t known until very recently that RNA comes in a circular form; the linear form has long been known. But the UCLA scientists identified more than 400 circular RNAs in human saliva — the first discovery of circular RNA in saliva or any body fluid — including 327 forms that were previously unknown.
Circular RNA’s function in saliva is not entirely understood, although it does serve as a sponge for tiny RNA molecules called microRNAs, which bind to it.
“Circular RNAs in saliva may be protecting other RNAs,” said Xiao, who also is a member of UCLA’s Molecular Biology Institute. It’s likely, she said, that circular RNAs in saliva protect microRNAs from being degraded.
MicroRNAs, which once seemed to be little more than molecular noise, play important roles in many cell types, and have been implicated in cancers and other diseases, Xiao said. One microRNA can regulate hundreds of genes, she said.
The scientists compared microRNA levels in saliva to those in the blood and other body fluids, and found the levels of microRNA in blood and in saliva are very similar — indicating that a saliva sample would be a good measure of microRNAs in the body.
They also found that saliva contains another class of small RNAs, called piwi-interacting RNAs, or piRNAs, which are produced by stem cells, skin cells and germ cells. There are very few piRNAs in blood and most other body fluids, but Xiao’s analysis showed that piRNA are abundant in saliva. Although their function is not yet known, Xiao said they may protect the body from viral infection.
While most RNA molecules translate genetic code from DNA to make proteins, there is also a class called non-coding RNAs that does not.
“Saliva carries with it non-coding RNAs, microRNAs, piRNAs and circRNAs that are biomarkers for disease and health monitoring,” said Wong, who also is associate dean of research at the UCLA School of Dentistry. “Had we not done this collaboration, we would never know that non-coding RNAs, microRNAs, piRNAs and circRNAs exist in saliva.”
Their overriding conclusion is that saliva has tremendous medical and scientific value. In the not-too-distant future, dentists might be able to take saliva samples to analyze for a variety of diseases. And, Wong says, the research could lead to a new category of self-diagnostic devices. “This could indicate that wearable gear that informs you whether you have a disease — even before you have any symptoms — is almost here,” he said.
The Latest on: Molecular diagnostics
via Google News
The Latest on: Molecular diagnostics
- Qiagen Snags FDA Nod For Molecular Diagnostic System, Announces US Launch on May 20, 2019 at 11:17 am
Qiagen NV (NYSE: QGEN) shares were spiking higher Monday following the announcement of FDA approval for its molecular diagnostic testing system. What Happened Germany-based Qiagen, a provider of ... […]
- Cancer Diagnostic Company Biocept's Stock Doubles In Value: What You Need To Know on May 20, 2019 at 8:27 am
Shares of Biocept Inc (NASDAQ: BIOC), a molecular diagnostics company specializing in biomarker analysis of circulating tumor-associated DNA, are making a strong upward move Monday. Biocept announced ... […]
- NGS Sample Preparation Market - Global Forecast to 2024: Improving Reimbursement Scenario for NGS-Based Diagnostic Tests on May 20, 2019 at 2:52 am
Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: ... […]
- Molecular Diagnostics Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019 - 2023 on May 19, 2019 at 11:51 pm
May 20, 2019 (AB Digital via COMTEX) -- Global Molecular Diagnostics Industry New Study On “2019-2023 Molecular Diagnostics Market Global Key Player, Demand, Growth, Opportunities and Analysis ... […]
- Molecular Diagnostics Market to Register a Stout Growth by 2026-end Future Market Insights Report on May 17, 2019 at 10:09 am
May 17, 2019 (MARKITWIRED via COMTEX) -- Molecular diagnostics is a method of analyzing and identifying the biological markers in the genome and proteome in order to identify gene expression by ... […]
- Molecular Diagnostics Technologies, Markets and Compettitive Landscape Report 2019 Featuring Profiles of 269 Companies on May 16, 2019 at 6:50 am
Dublin, May 16, 2019 (GLOBE NEWSWIRE) -- The "Molecular Diagnostics - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This ... […]
- Point of Care Molecular Diagnostics Market To Amass Huge Share| $2.5 Bn by 2024 on May 15, 2019 at 4:32 am
The Point of Care Molecular Diagnostics Market is set to exceed USD 2.5 billion by 2024; according to a new research study published by Global Market Insights, Inc. Increasing awareness regarding ... […]
- Molecular Diagnostics 2019 Global Market Size, Market Share, Status and Forecast to 2025 on May 14, 2019 at 11:59 pm
Molecular diagnostics market employs a range of systems, including real-time PCR systems, liquid handling systems, and DNA extraction systems, among others. Real-time PCR systems are commonly known as ... […]
- HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q1 2019 Results - Earnings Call Transcript on May 9, 2019 at 7:48 pm
HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Q1 2019 Earnings Conference Call May 9, 2019 4:30 PM ET Company Participants Monique Kosse - Investor Relations John Lubniewski - Chief Executive ... […]
- HTG Molecular Diagnostics, Inc. (HTGM) Reports Q1 Loss, Tops Revenue Estimates on May 9, 2019 at 5:52 pm
HTG Molecular Diagnostics, Inc. (HTGM) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.22 per share a year ago. ... […]
via Bing News